This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit December 10, 2014

Home   About   Join Us   Annual Conference   The Voice   Career Center   Resources   Education Plus  

 

Update on promising vaccines in the pipeline
Healio
Mark H. Sawyer, M.D., professor of clinical pediatrics at University of California San Diego, offers his insight on the vaccines in the pipeline he believes are most promising for pediatric patients, including an investigational 9-valent HPV vaccine and serogroup B meningococcal vaccine.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  


ASCT National Cytotechnology Day Design contest
ASCT
The winner will receive $150 cash. Submit your design and slogan by March 1, 2015.

Entries should be submitted to: mzanon@asct.com
The award will be mailed March 27 and the winning design acknowledged at the 2015 ASCT Annual Conference, May 1-3, Sheraton Hotel, Nashville, TN.

Rules:
  1. Design must be an original concept of the applicant.
  2. Artwork cannot be an advertising copyright or reproduction of a trademark.
  3. Design and slogan selected becomes the property of ASCT.
  4. Principle winner cannot be a minor.
  5. All entries received after the March 1, 2015 deadline will not be accepted.
  6. All entries must be submitted with applicants name, address, email and phone number.
To learn more about National Cytotechnology Day, click here.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Check out the new ASCT gift items
ASCT










New ASCT gift items are now available. Add Herpes and Candida plushies to your gift list! ASCT offers something for everyone in your lab — microscope lapel pins, HPV plushies, cytology playing cards, ASCT tote bags, polo shirts, baseball caps and cytology notecards. Check them out at www.asct.com. Happy Shopping!

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


UPCOMING EVENTS

Date Event Location More information
Jan. 14, 2015
2 p.m. EST
Quality Assurance Planning: A Practical Approach to Quality Management Systems Madison, WI


John Shalkham, SCT(ASCP), Manager, Disease Prevention Division Director, Office of Quality Assurance, Wisconsin State Laboratory of Hygiene, University of Wisconsin-Madison,
More info |

Jan. 17, 2015

Arizona Cytology Association Annual Conference

Gilbert, AZ

MD Anderson Center
Save the date! More information to follow in a future ViewPoint
Feb. 11, 2015
2 p.m. EST
Cytohistology of Pulmonary Neuroendocrine Tumors Atlanta, GA


Momin T. Siddiqui, M.D., Professor of Pathology, Director of Cytopathology, Emery University Hospital
More info |
March 11, 2015
2 p.m. EST
CPTs and ICDs: Understanding the Basics of Cytology Billing Pittsburgh, PA


Jackie Cuda, BS, SCT(ASCP), Cytology Supervisor, University of Pittsburgh Medical Center Pittsburgh, PA
More info |

Available for 6 months after subscribing

Quality Assessment Center (QAC) Document Control for Cytopathology Workbench

Your PC

Details

Available for 6 months after subscribing

Quality Assessment Center (QAC)
The LEAN Cytopathology Laboratory Workbench

Your PC

Details


INDUSTRY NEWS


WHO guidelines look to simplify, shorten HPV vaccine regimen
UPI
In its effort to control and prevent cervical cancer, the World Health Organization is updating its screening and vaccination guidelines for doctors and patients around the globe. Under the new guidelines, experts with WHO are recommending the HPV vaccine be shortened from a three-shot schedule to a two-shot schedule.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


CMS considers coverage of dual testing for cervical cancer
Modern Healthcare
The CMS has decided to follow the American Academy of Family Physicians' suggestion that it begin a national coverage analysis to determine if the agency should pay for women to get a combination Pap smear and HPV test every five years to screen for cervical cancer. Medicare now covers a screening pelvic examination and Pap test for all female beneficiaries at 12 or 24 month intervals, but does not cover HPV testing. The scope of the current review is limited to screening for cervical cancer along with HPV testing, CMS said in a posting on its site.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


MORE NEWS


Insights into common genetic mechanisms may form the basis for new tests performed by clinical pathology labs
Dark Daily
New discoveries about the interaction of genes and transcription factors in creating different types of RNA will be of interest to pathologists and clinical chemists performing genetic tests and molecular diagnostic assays in their medical laboratories. The goal of this research is to better understand hereditary genetic disease in humans.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
Looking for similar articles? Search here, keyword Labs


Study shows men can get oral HPV infection from women
HealthDay via WLTZ-TV
Men are at increased risk for oral human papillomavirus infection if their female sex partners have oral and/or genital HPV infections, a new study shows. The findings suggest that HPV transmission occurs through both oral-oral and oral-genital routes, according to the authors of the study.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Can you beat cancer? It depends on where you live
MedCity News
With information from one of the most intense cancer research studies ever conducted (surveying 25.7 million people), it's clear that where you live has something to do with how likely you are to survive cancer. For example, 9 out of 10 kids with lymphblastic leukemia in the U.S. will survive. Compare that to the 16 percent survival rate in Jordan. In countries like Mauritius and Norway, more than 70 percent of cervical cancer patients have a five-year survival rate. In Libya, its less than 40 percent of patients.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Miss an issue of ASCT Viewpoint? Click here to visit the ASCT Viewpoint archive page.


Approved breast cancer drug offers hope for the treatment of blood disorders
Medical Xpress
Blood cancers are more common in men than in women, but it has not been clear why this is the case. A study published by Cell Press in Cell Stem Cell provides an explanation, revealing that female sex hormones called estrogens regulate the survival, proliferation and self-renewal of stem cells that give rise to blood cancers. Moreover, findings in mice with blood neoplasms — the excessive production of certain blood cells — suggest that a drug called tamoxifen, which targets estrogen receptors and is approved for the treatment of breast cancer, may also be a valuable strategy for blocking the development of blood neoplasms in humans.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Software speeds detection of diseases and cancer treatment targets
Phys.org
Los Alamos National Laboratory has released an updated version of powerful, award-winning bioinformatics software that is now capable of identifying DNA from viruses and all parts of the Tree of Life — putting diverse problems such as identifying pathogen-caused diseases,selection of therapeutic targets for cancer treatment, and optimizing yields of algae farms within relatively easy reach for healthcare professionals, researchers and others.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


 

ASCT Viewpoint
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Esther Cho, Content Editor, 469.420.2671   
Contribute news

This edition of ASCT Viewpoint was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
Nov. 26, 2014
Nov. 12, 2014
Oct. 22, 2014
Oct. 8, 2014



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063